Reuters Insider - Avoid biotechs; buy into India - fund manager

Sstartrade Tech

15/10/2015 19:40

Click the following link to watch video:                              
 https://insider.thomsonreuters.com/link.html?cn=share&cid=1498612&shareToken=Mzo2MDc5YmU1Ny04Njc3LTRjOGEtODdiZC02YjczOTNjMmNiZjU%3D&playerName=ReutersNews 
                                                                       
 Source:             Thomson Reuters                                   
                                                                       
 Description:        Biotech stocks are still too pricey, but India is 
                     a long-term buy, says Vespula Capital's Jeff      
                     Tomasulo.                                         
 
 
(To access all exclusive Reuters Insider programming visit: http://insider.thomsonreuters.com) 
 
 Short Link:  http://reut.rs/1NJP3O8